Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Serplulimab by Shanghai Henlius Biotech for Adenocarcinoma Of The Gastroesophageal Junction: Likelihood of Approval
Serplulimab is under clinical development by Shanghai Henlius Biotech and currently in Phase II for Adenocarcinoma Of The Gastroesophageal Junction....
Serplulimab by Shanghai Henlius Biotech for Gastric Cancer: Likelihood of Approval
Serplulimab is under clinical development by Shanghai Henlius Biotech and currently in Phase II for Gastric Cancer. According to GlobalData,...
Serplulimab by Shanghai Henlius Biotech for Small-Cell Lung Cancer: Likelihood of Approval
Serplulimab is under clinical development by Shanghai Henlius Biotech and currently in Phase III for Small-Cell Lung Cancer. According to...
Serplulimab by Shanghai Henlius Biotech for Esophageal Cancer: Likelihood of Approval
Serplulimab is under clinical development by Shanghai Henlius Biotech and currently in Phase II for Esophageal Cancer. According to GlobalData,...